Imugene Ltd - Asset Resilience Ratio

Latest as of December 2025: 23.07%

Imugene Ltd (IMU) has an Asset Resilience Ratio of 23.07% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$15.61 Million

≈ $11.04 Million USD Cash + Short-term Investments

Total Assets

AU$67.67 Million

≈ $47.88 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (1995–2025)

This chart shows how Imugene Ltd's Asset Resilience Ratio has changed over time. Check IMU capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Imugene Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Imugene Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$14.14 Million	20.89%
Short-term Investments	AU$1.47 Million	2.18%
Total Liquid Assets	AU$15.61 Million	23.07%

Asset Resilience Insights

Good Liquidity Position: Imugene Ltd maintains a healthy 23.07% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Imugene Ltd Industry Peers by Asset Resilience Ratio

Compare Imugene Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Imugene Ltd (1995–2025)

The table below shows the annual Asset Resilience Ratio data for Imugene Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	2.49%	AU$2.08 Million ≈ $1.47 Million	AU$83.59 Million ≈ $59.14 Million	-31.20pp
2024-06-30	33.69%	AU$51.01 Million ≈ $36.09 Million	AU$151.40 Million ≈ $107.12 Million	+8.55pp
2023-06-30	25.14%	AU$49.54 Million ≈ $35.05 Million	AU$197.06 Million ≈ $139.43 Million	+5.49pp
2022-06-30	19.65%	AU$29.00 Million ≈ $20.52 Million	AU$147.61 Million ≈ $104.44 Million	-9.60pp
2021-06-30	29.25%	AU$21.00 Million ≈ $14.86 Million	AU$71.81 Million ≈ $50.81 Million	-9.10pp
2020-06-30	38.34%	AU$25.00 Million ≈ $17.69 Million	AU$65.20 Million ≈ $46.14 Million	-17.52pp
2019-06-30	55.87%	AU$17.20 Million ≈ $12.17 Million	AU$30.78 Million ≈ $21.78 Million	+9.62pp
2018-06-30	46.25%	AU$7.82 Million ≈ $5.53 Million	AU$16.91 Million ≈ $11.97 Million	+8.27pp
2017-06-30	37.97%	AU$4.81 Million ≈ $3.41 Million	AU$12.68 Million ≈ $8.97 Million	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$9.54 Million ≈ $6.75 Million	--
1996-06-30	4.18%	AU$387.00K ≈ $273.83K	AU$9.25 Million ≈ $6.54 Million	+0.33pp
1995-06-30	3.86%	AU$460.00K ≈ $325.48K	AU$11.93 Million ≈ $8.44 Million	--

pp = percentage points

About Imugene Ltd

AU:IMU Australia Biotechnology

Market Cap

$25.22 Million

AU$35.65 Million AUD

Market Cap Rank

#24306 Global

#967 in Australia

Share Price

AU$0.08

Change (1 day)

-1.18%

52-Week Range

AU$0.08 - AU$0.45

All Time High

AU$0.61